4//SEC Filing
Easom Eric 4
Accession 0000950170-25-081041
CIK 0001880438other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:46 PM ET
Size
8.0 KB
Accession
0000950170-25-081041
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-06-02$1.07/sh+10,000$10,665→ 256,380 total
Holdings
- 1,065,766(indirect: See Footnote)
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.05 to $1.0699 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
- [F2]Includes (i) 145,250 restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date and (ii) a balance of 99,000 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of each such date.
- [F3]Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
- [F4]Consists of shares of Common Stock held by the C. Easom Irrevocable Trust dated October 8, 2021.
- [F5]Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914503
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:46 PM ET
- Size
- 8.0 KB